<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Tangential-Flow-Filtration on Bioecon</title><link>https://en.bioecon.ru/technologies/tangential-flow-filtration/</link><description>Recent content in Tangential-Flow-Filtration on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Sun, 26 Jul 2026 12:15:59 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/technologies/tangential-flow-filtration/index.xml" rel="self" type="application/rss+xml"/><item><title>mRNA / LNP manufacturing equipment</title><link>https://en.bioecon.ru/technology/mrna-lnp-manufacturing-equipment/</link><pubDate>Sat, 25 Jul 2026 20:35:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/mrna-lnp-manufacturing-equipment/</guid><description>The mixers, skids and continuous-flow reactors that bring an mRNA payload and a four-lipid ethanol blend together in microseconds to self-assemble 80–120 nm lipid nanoparticles — the hardware layer behind every commercial mRNA vaccine and the in-vivo delivery system for the next generation of gene therapy.</description></item><item><title>Downstream Purification &amp; Bioseparation</title><link>https://en.bioecon.ru/technology/downstream-purification-bioseparation/</link><pubDate>Fri, 19 Jun 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/downstream-purification-bioseparation/</guid><description>Downstream purification converts crude bioreactor harvests into clinical-grade drug substance — chromatography (Protein A, IEX, HIC), tangential-flow filtration, and viral clearance together account for &amp;gt;50% of biomanufacturing CAPEX. The global DSP market exceeds $5B and grows at &amp;gt;8% CAGR driven by mAb and cell-gene therapy demand.</description></item></channel></rss>